A Philadelphia judge on Friday slashed a $8 billion jury verdict in a lawsuit over the marketing of the antipsychotic drug Risperdal, reducing the punitive damages to $6.8 million.
The verdict, in October, was the first to award punitive damages against Janssen Pharmaceuticals, a Johnson &...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.